C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 495/14 (2006.01) A61K 31/55 (2006.01) A61K 31/675 (2006.01) C07D 471/14 (2006.01) C07D 491/147 (2006.01) C07D 498/14 (2006.01) C07D 513/14 (2006.01) C07F 9/6561 (2006.01)
Patent
CA 2210632
Tricyclic compound of general formula (I) as defined herein which exhibit antagonist activity at V1 and/or V2 receptors and exhibit in vivo vasopressin antagonist activity, methods for using such compounds in treating diseases characterized by excess renal reabsorption of water, and process for preparing such compounds.
On définit un composé tricyclique de la formule générale (I) qui montre une activité antagoniste aux récepteurs V1 et/ou V2 ainsi qu'une activité antagoniste de vasopressine in vivo. En outre, on décrit des méthodes d'utilisation de composés de ce type pour le traitement de maladies caractérisées par un excès de réabsorption de l'eau par le rein, ainsi qu'un processus de préparation de ces composés.
Albright Jay Donald
Delos Santos Efren Guillermo
Du Xuemei
Reich Marvin Fred
Venkatesan Aranapakam Mudumbai
American Cyanamid Company
Ridout & Maybee Llp
Wyeth Holdings Corporation
LandOfFree
Tricyclic benzazepine vasopressin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic benzazepine vasopressin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic benzazepine vasopressin antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1360075